42
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Migrant-inclusive healthcare delivery in the UK: Lessons learned from the COVID-19 Pandemic

      discussion

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The COVID-19 pandemic has highlighted the health inequalities experienced by many underserved migrants in the UK, but has also generated unique opportunities to reflect on lessons learned in migrant-inclusive healthcare delivery. 1 Some underserved migrant communities (foreign-born nationals including asylum seekers, refugees, undocumented migrants, low-skilled labour migrants) were at additional risk of infection and overrepresented among COVID-19 cases and death, due to a range of risk factors such as working in low paid, precarious, and public facing jobs, living in overcrowded accommodation and facing barriers to healthcare. 1 , 2 Although exemptions for free COVID-19 treatment and vaccination irrespective of immigration status were quickly put in place, they were undermined by unclear or delayed messaging to these communities and healthcare staff. The pandemic, however, clearly demonstrated that it was possible to rapidly design and implement more inclusive approaches to service delivery and public health communications. 2 , 3 Reflecting on the UK context, we discuss lessons learned in reducing access barriers, improving services delivery, building trust within migrant communities, and recommendations for ensuring migrant-inclusive healthcare in the UK and Europe. The pandemic exacerbated longstanding legal and access barriers that some migrants face when seeking healthcare. Migrants in England were less likely to use primary care than non-migrants before and during the first year of the pandemic, 4 as General Practices (GPs) ceased new registrations or, contrary to official guidance, demanded proof of address, identification, or evidence of immigration status when registering. 5 This restricted access to COVID-19 vaccination when roll-out began, which often required GP registration and an National Health Service (NHS) number. 2 , 5 , 6 For registered migrants, shifts from in-person to remote consultations posed challenges due to limited translation support and barriers to accessing care online. 2 , 6 However, as the vaccine roll-out gathered momentum, various inclusive vaccination campaigns began, including walk-in community vaccine centres with flexible timetables and mobile vaccination vans, outreach targeted at populations with low GP registration, providing assistance with GP registration at vaccination points, and working with community partners to ensure accessibility. 7 A period of research and reflection is now needed to formally evaluate what approaches to inclusive service delivery worked for future pandemics and importantly for current routine vaccine programmes. Rapid and clear public health messaging is key to an effective pandemic response. While Public Health England translated COVID-19 guidance into multiple languages from March 2020, there was a need make these translations rapidly available and to widen the selection of languages and formats. 6 Innovative communications campaigns from third sector organisations included DOTW COVID-19 Vaccine Confidence Toolkit which was co-designed with migrants and translated into twenty languages, information sessions at community and religious centres, and social media campaigns about vaccination delivered by migrant and ethnic minority healthcare workers across London.6, 7, 8 Public health messaging works better if it is co-designed with communities and delivered by trusted groups. 6 , 8 Some migrant communities have a well-founded distrust of official bodies. The UK's ‘hostile environment’ resulted in a suite of policies aiming to make life untenable in the UK for individuals without immigration status. Policies that restrict healthcare access such as charging for secondary care and data sharing between the NHS and immigration enforcement have impacted some migrants’ willingness to access NHS services. 3 , 6 The introduction of increasingly draconian immigration policies, such as the policy to send certain refugees to Rwanda, has exacerbated fear in public welfare services further. 7 Rebuilding trust with migrant communities was and will continue to be key, and examples of good practice seen during the pandemic in the UK include partnerships with community groups, no questions-asked access to testing and vaccination, and clear communication on healthcare entitlements. 8 , 9 Given the disproportionate impact of the pandemic on migrants, we call on the UK COVID-19 Inquiry to properly consider the experiences of migrants, including those with insecure immigration status during the pandemic. 10 Panel 1 summarises a call for action in key areas of relevance to the UK and other European countries. The pandemic has demonstrated that the UK, and other countries across Europe, can integrate underserved migrants into an emergency health response, with a wider acceptance now that migrants deserve access to routine healthcare. As has been seen in the UK, building migrant-inclusive health is politically challenging. However, without an inclusive approach, our ability to response adequately and equitably to any future emergencies will be severely hampered. Key areas requiring action: 1. Action by governments to address the structural barriers that lead to the marginalisation of certain migrant groups, including action on the intersection of ethnicity, gender, disability, sexuality, and age. 2. Any national reviews of the impact of COVID-19 on populations should include the experiences of migrants. 3. Action to ensure universal healthcare access for all migrants, including inclusive healthcare data systems that are not shared with immigration authorities. 4. There is an urgent need to improve migrant-disaggregated datasets pertaining to health and vaccination. 5. Any healthcare organisations or governments managing future health emergency responses should ensure any interventions and messaging are co-designed with local migrant communities to ensure maximum uptake and access. 6. Governments and healthcare systems should ensure all public health messaging is culturally and linguistically appropriate, and available in a range of languages and formats with routinely available translation teams to ensure rapidly updated information is available to all migrant communities. 7. Action by local and national media, advocacy, and governmental organisations to reframe the narrative on migration. Alt-text: Unlabelled box Doctors of the world expert consortium on refugee and migrant health members Professor Jenny Phillimore, Institute for Research into Superdiversity, University of Birmingham; Professor Martin McKee, Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine; Helen Donovan, Royal College of Nursing; Professor Cornelius Katona, Helen Bamber Foundation; Professor Robert W Aldridge, Institute of Health Informatics, University College London; Professor Jon S Friedland, St. George's, University of London; Dr Laura B Nellums, University of Nottingham; Professor Catherine O'Donnell, University of Glasgow; Dr Ann Lorek, King's College London. Contributors All authors conceptualised this comment. RB and KS wrote the first draft, with major inputs from all authors. All authors have approved the final version of the manuscript for submission. Declaration of interests All authors declare no conflict of interests.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: found

          Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review

          Background Migrants in high-income countries may be at increased risk of COVID-19 due to their health and social circumstances, yet the extent to which they are affected and their predisposing risk factors are not clearly understood. We did a systematic review to assess clinical outcomes of COVID-19 in migrant populations, indirect health and social impacts, and to determine key risk factors. Methods We did a systematic review following PRISMA guidelines (PROSPERO CRD42020222135). We searched multiple databases to 18/11/2020 for peer-reviewed and grey literature on migrants (foreign-born) and COVID-19 in 82 high-income countries. We used our international networks to source national datasets and grey literature. Data were extracted on primary outcomes (cases, hospitalisations, deaths) and we evaluated secondary outcomes on indirect health and social impacts and risk factors using narrative synthesis. Results 3016 data sources were screened with 158 from 15 countries included in the analysis (35 data sources for primary outcomes: cases [21], hospitalisations [4]; deaths [15]; 123 for secondary outcomes). We found that migrants are at increased risk of infection and are disproportionately represented among COVID-19 cases. Available datasets suggest a similarly disproportionate representation of migrants in reported COVID-19 deaths, as well as increased all-cause mortality in migrants in some countries in 2020. Undocumented migrants, migrant health and care workers, and migrants housed in camps have been especially affected. Migrants experience risk factors including high-risk occupations, overcrowded accommodation, and barriers to healthcare including inadequate information, language barriers, and reduced entitlement. Conclusions Migrants in high-income countries are at high risk of exposure to, and infection with, COVID-19. These data are of immediate relevance to national public health and policy responses to the pandemic. Robust data on testing uptake and clinical outcomes in migrants, and barriers and facilitators to COVID-19 vaccination, are urgently needed, alongside strengthening engagement with diverse migrant groups.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees

            Introduction Early evidence confirms lower COVID-19 vaccine uptake in established ethnic minority populations, yet there has been little focus on understanding vaccine hesitancy and barriers to vaccination in migrants. Growing populations of precarious migrants (including undocumented migrants, asylum seekers and refugees) in the UK and Europe are considered to be under-immunised groups and may be excluded from health systems, yet little is known about their views on COVID-19 vaccines specifically, which are essential to identify key solutions and action points to strengthen vaccine roll-out. Methods We did an in-depth semi-structured qualitative interview study of recently arrived migrants (foreign-born, >18 years old; <10 years in the UK) to the UK with precarious immigration status between September 2020 and March 2021, seeking their input into strategies to strengthen COVID-19 vaccine delivery and uptake. We used the ‘Three Cs’ model (confidence, complacency and convenience) to explore COVID-19 vaccine hesitancy, barriers and access. Data were analysed using a thematic framework approach. Data collection continued until data saturation was reached, and no novel concepts were arising. The study was approved by the University of London ethics committee (REC 2020.00630). Results We approached 20 migrant support groups nationwide, recruiting 32 migrants (mean age 37.1 years; 21 [66%] female; mean time in the UK 5.6 years [SD 3.7 years]), including refugees (n = 3), asylum seekers (n = 19), undocumented migrants (n = 8) and migrants with limited leave to remain (n = 2) from 15 different countries (5 WHO regions). 23 (72%) of 32 migrants reported being hesitant about accepting a COVID-19 vaccine and communicated concerns over vaccine content, side-effects, lack of accessible information in an appropriate language, lack of trust in the health system and low perceived need. Participants reported a range of barriers to accessing the COVID-19 vaccine and expressed concerns that their communities would be excluded from or de-prioritised in the roll-out. Undocumented migrants described fears over being charged and facing immigration checks if they present for a vaccine. All participants (n = 10) interviewed after recent government announcements that COVID-19 vaccines can be accessed without facing immigration checks remained unaware of this. Participants stated that convenience of access would be a key factor in their decision around whether to accept a vaccine and proposed alternative access points to primary care services (for example, walk-in centres in trusted places such as foodbanks, community centres and charities), alongside promoting registration with primary care for all, and working closely with communities to produce accessible information on COVID-19 vaccination. Conclusions Precarious migrants may be hesitant about accepting a COVID-19 vaccine and face multiple and unique barriers to access, requiring simple but innovative solutions to ensure equitable access and uptake. Vaccine hesitancy and low awareness around entitlement and relevant access points could be easily addressed with clear, accessible, and tailored information campaigns, co-produced and delivered by trusted sources within marginalised migrant communities. These findings have immediate relevance to the COVID-19 vaccination initiatives in the UK and in other European and high-income countries with diverse migrant populations. Funding NIHR
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Migrants’ primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series analysis

              Background How international migrants access and use primary care in England is poorly understood. We aimed to compare primary care consultation rates between international migrants and non-migrants in England before and during the COVID–19 pandemic (2015–2020). Methods Using data from the Clinical Practice Research Datalink (CPRD) GOLD, we identified migrants using country-of-birth, visa-status or other codes indicating international migration. We linked CPRD to Office for National Statistics deprivation data and ran a controlled interrupted time series (ITS) using negative binomial regression to compare rates before and during the pandemic. Findings In 262,644 individuals, pre-pandemic consultation rates per person-year were 4.35 (4.34–4.36) for migrants and 4.60 (4.59–4.60) for non-migrants (RR:0.94 [0.92–0.96]). Between 29 March and 26 December 2020, rates reduced to 3.54 (3.52–3.57) for migrants and 4.2 (4.17–4.23) for non-migrants (RR:0.84 [0.8–0.88]). The first year of the pandemic was associated with a widening of the gap in consultation rates between migrants and non-migrants to 0.89 (95% CI 0.84–0.94) times the ratio before the pandemic. This widening in ratios was greater for children, individuals whose first language was not English, and individuals of White British, White non-British and Black/African/Caribbean/Black British ethnicities. It was also greater in the case of telephone consultations, particularly in London. Interpretation Migrants were less likely to use primary care than non-migrants before the pandemic and the first year of the pandemic exacerbated this difference. As GP practices retain remote and hybrid models of service delivery, they must improve services and ensure primary care is accessible and responsive to migrants’ healthcare needs. Funding This study was funded by the Medical Research Council (MC_PC 19070 and MR/V028375/1) and a Wellcome Clinical Research Career Development Fellowship (206602).
                Bookmark

                Author and article information

                Journal
                Lancet Reg Health Eur
                Lancet Reg Health Eur
                The Lancet Regional Health - Europe
                The Author(s). Published by Elsevier Ltd.
                2666-7762
                7 September 2022
                October 2022
                7 September 2022
                : 21
                : 100505
                Affiliations
                [a ]Research Fellow, Institute of Health Informatics, University College London, 222 Euston Road, London NW1 2DA, United Kingdom
                [b ]Migrant Health Lead, UK Faculty of Public Health
                [c ]NIHR Academic Public Health Doctor, Faculty of Public Health and Policy, LSHTM, 15-17 Tavistock Place, London WC1H 9SH, United Kingdom
                [d ]Head of Policy & Advocacy, Doctors of the World UK, 29, One Canada Square, London E14 5AA, United Kingdom
                [e ]Associate Professor, Migrant Health Research Group, Institute for Infection and Immunity, St George's University of London, London SW17 0QT, United Kingdom
                Author notes
                [* ]Corresponding author at: Institute of Health Informatics, University College London, 222 Euston Road, London NW1 2DA, United Kingdom.
                [1]

                Joint first authors.

                Article
                S2666-7762(22)00201-0 100505
                10.1016/j.lanepe.2022.100505
                9450880
                36091080
                06579457-900f-4cbd-a591-4d00be660299
                © 2022 The Author(s)

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Comment

                Comments

                Comment on this article